If you have watched people in your gym run hormones with no labs and no oversight, you already know the difference between optimizing and gambling. The dividing line is not the molecule. It is the monitoring.
Supervised hormone therapy is a feedback loop: a provider measures, interprets in context, and adjusts. This article walks through the core panel an independent provider typically watches on testosterone therapy, what each marker means, and why the discipline of follow-up is what actually protects you. This is educational information, not medical advice, and it is not a recommendation to start any specific medication.
Why monitoring is the whole point
The Endocrine Society's clinical practice guideline on testosterone therapy is built around a simple idea: you diagnose with repeated, morning measurements, and you follow patients over time to keep values in a healthy range and to catch side effects early [1]. That means baseline labs before anything begins, then recheck intervals during the first year, then periodically after that [1]. A protocol without labs is not a lighter version of this. It is a different thing entirely.
For someone who trains seriously, this matters twice over. Training, sleep debt, and hard cutting all move hormones on their own. A single number in isolation tells a provider very little. A trend, read against symptoms and the rest of the panel, tells them a great deal.
Free testosterone: the fraction that acts
Most testosterone in the blood is bound, largely to sex hormone binding globulin (SHBG) and albumin. Only a small unbound ("free") fraction, plus the loosely albumin-bound portion, is biologically available to tissue [2]. That is why two people with identical total testosterone can feel very different: SHBG differs, and the free fraction differs with it.
SHBG shifts with age, body composition, thyroid status, and other factors, so total testosterone alone can mislead [2]. When results and symptoms do not line up, guidelines describe measuring or calculating free testosterone as a next step, ideally by reliable methods such as equilibrium dialysis or a validated calculation using total testosterone, SHBG, and albumin [1][2]. For a trainer, this is the marker that maps most closely to how you actually feel and recover, which is exactly why a thorough provider looks past the single total number.
Source: [1] Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline (Journal of Clinical Endocrinology & Metabolism), [2] Utility, Limitations, and Pitfalls in Measuring Testosterone: An Endocrine Society Position Statement, [3] Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men (Finkelstein et al., New England Journal of Medicine)
Estradiol: not the enemy, a variable to manage
Estradiol is not a female hormone that men should drive to zero. In men, a meaningful share of estradiol comes from the aromatization of testosterone, and it plays real roles in bone density, libido, and cardiovascular and metabolic health [3][4]. The landmark work by Finkelstein and colleagues, published in the New England Journal of Medicine, showed that suppressing estradiol in men produced distinct effects separate from testosterone itself, particularly on body fat and sexual function [3].
That is the whole case against gym-broscience aromatase suppression. Crushing estradiol to chase a "dry" look can undercut the very outcomes, bone, libido, mood, and metabolic health, that someone optimizing for the long run should protect [3][4]. A responsive provider watches estradiol as part of the picture and interprets it alongside testosterone and symptoms, rather than reflexively suppressing it. For the reader who wants estrogen managed intelligently rather than ignored or blunt-forced, this is where depth shows up.
Hematocrit: the safety marker you cannot skip
Testosterone stimulates red blood cell production, and one of the most common measurable effects of therapy is a rise in hematocrit, the percentage of blood made up of red cells [1][5]. Erythrocytosis (an excessive rise) is the reason a complete blood count is a standing part of monitoring, not an optional extra [1].
The Endocrine Society guideline explicitly lists checking hematocrit at baseline, then during the first months and at intervals thereafter, and describes acting when it climbs too high [1]. This is precisely the kind of routine safety check that unsupervised use skips, and it is not trivial: an unchecked hematocrit is a genuine safety issue. A coordinated path treats this number as non-negotiable.
% hematocrit · marker = Common action threshold
Source: [5] Testosterone-Induced Erythrocytosis: Mechanisms and Management (NIH/PMC review)
PSA and the rest of the standing panel
For men in the relevant age range, the guideline also describes prostate monitoring, including PSA and clinical evaluation, on a defined schedule during therapy [1]. Depending on the clinical picture, a provider may also track lipids, metabolic markers, and other values over time. The point is not a longer checklist for its own sake. It is that legitimate therapy is defined by structured, repeated measurement and interpretation by a licensed clinician [1].
Fertility: the conversation to have before you start
This is the part too often learned the hard way. Exogenous testosterone suppresses the body's own signaling from the pituitary, which reduces intratesticular testosterone and can impair sperm production. The FDA's own labeling for testosterone products notes that use can lead to reduced sperm counts, and reproductive health resources describe this suppression of spermatogenesis directly [6][7]. In many men this is reversible after stopping, but recovery is not guaranteed and can take time [7].
If future fertility matters to you, that fact belongs at the very front of the conversation with a provider, before any decision, so that goals, baseline testing, and alternatives can all be weighed. A provider who takes an athlete seriously is one who raises this without being asked. This is exactly the discussion the gym shortcut skips, and exactly the one that separates a considered path from a botched cycle.
What disciplined follow-up actually looks like
Put together, the pattern from the guidelines is consistent: baseline labs and symptom review, a recheck in the first months, further checks across the first year, then periodic monitoring, with adjustments driven by data and how you feel [1]. That responsiveness, adjusting based on trends rather than waiting a year between conversations, is the difference between care that keeps pace with a serious training life and care that does not.
Where Velri fits
Velri is a technology and coordination company, not a medical provider. Velri does not diagnose, treat, or prescribe. What Velri coordinates is the structure this article describes: convenient lab collection, a visit with an independent, physician-led Provider Group, and, if a provider determines it is appropriate, fulfillment through an independent licensed pharmacy. Whether therapy is appropriate, and whether any prescription is written, is always decided by an independent licensed provider. A prescription is never guaranteed.
If a compounded medication is ever part of a provider's plan, note this: compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. Velri's coordinated services currently start in Nevada, with more states rolling out over time.
This article is educational and is not medical advice. Talk with a licensed provider about your individual situation, your goals, and your fertility priorities before making any decision.



